PepsiCo earnings beat estimates, but demand for drinks and snacks drops in North America
Read more at CNBC
-
Regeneron’s earnings boosted by demand for blockbuster eye drug Eylea
A higher-dose formulation of Eylea saw U.S. sales more than doubleMarketWatch - 59m -
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.CNBC - 1h -
Tesla fourth-quarter results miss estimates as automotive revenue drops 8%
Tesla reported weaker-than-expected earnings and revenue for the quarter that ended in December.CNBC - 5d -
IBM shares rise 9% on earnings beat
In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business.CNBC - 5d -
Levi beats earnings estimates but expects pressure this year from strong U.S. dollar
Levi expects its sales to slow in the current fiscal year because of the strong U.S. dollar and one fewer selling week.CNBC - 5d -
President Donald Trump says he'll 'demand that interest rates drop immediately'
The comments represented an initial strike at Fed officials, with whom Trump had a highly contentious relationship during his first term in office.CNBC - Jan. 23 -
Procter & Gamble earnings beat estimates as shoppers buy more household staples
Procter & Gamble beat quarterly earnings and revenue estimates and also reiterated its fiscal 2025 forecast.CNBC - Jan. 22 -
Charles Schwab hints at stock buybacks after beating Wall Street estimates
Charles Schwab also beat Wall Street’s fourth-quarter earnings estimate and reversed a revenue decline from the year-ago quarter.MarketWatch - Jan. 21 -
Swissquote Expects Results To Beat Views on Crypto Demand
The online bank said its results for 2024 should exceed market expectations as it was boosted by cryptocurrency trading.The Wall Street Journal - Jan. 17
More from CNBC
-
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.CNBC - 1h -
PayPal reports fourth-quarter earnings beat as growth picks up at Venmo
PayPal reported better-than-expected fourth-quarter earnings and revenue in its quarterly report on Tuesday.CNBC - 4m -
Warren Buffett's Berkshire Hathaway scoops up more Sirius XM, boosting stake to 35%
The Omaha, Nebraska-based conglomerate purchased roughly 2.3 million shares for about $54 million in separate transactions Thursday through Monday.CNBC - 25m -
McDonald's Shamrock Shake returns — and so does Grimace's uncle
McDonald's is bringing back the mascot Uncle O'Grimacey, Grimace's uncle, to promote the seasonal milkshake.CNBC - 28m -
Former NATO chief Stoltenberg to become Norway's finance minister after Oslo government collapse
NATO's former Secretary General Jens Stoltenberg is set to become Norway's next finance minister on Tuesday, the country's finance ministry confirmed to CNBC.CNBC - 4h
More in Business
-
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.CNBC - 3m -
PayPal reports fourth-quarter earnings beat as growth picks up at Venmo
PayPal reported better-than-expected fourth-quarter earnings and revenue in its quarterly report on Tuesday.CNBC - 4m -
Trump Promised a Cap on Credit Card Interest Rates. Here’s His Chance.
Senators Bernie Sanders and Josh Hawley say they will propose a 10 percent limit on credit card interest rates.The New York Times - 4m -
The tariff wars aren’t over. China hits back over new 10% tariffs.
U.S. agreements with Canada and Mexico stopped tariffs before they were to enter into effect, but the trade war between the world’s top two economies is continuing.MarketWatch - 5m -
Cyber cop specialist SailPoint eyes $1 billion in proceeds in IPO return
Private-equity firm Thoma Bravo taking company public at an estimated market cap of $11 billion in its return to the stock marketMarketWatch - 20m